Xiuyi Pan

572 total citations
17 papers, 132 citations indexed

About

Xiuyi Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiuyi Pan has authored 17 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Xiuyi Pan's work include Renal cell carcinoma treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and Renal and related cancers (5 papers). Xiuyi Pan is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and Renal and related cancers (5 papers). Xiuyi Pan collaborates with scholars based in China, Germany and Oman. Xiuyi Pan's co-authors include Ni Chen, Qiao Zhou, Mengni Zhang, Xiaoxue Yin, Xingming Zhang, Hao Zeng, Pengfei Shen, Miao Xu, Ling Nie and Xueqin Chen and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and The American Journal of Surgical Pathology.

In The Last Decade

Xiuyi Pan

15 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuyi Pan China 6 90 68 38 33 24 17 132
Mahmut Akgül United States 7 115 1.3× 76 1.1× 31 0.8× 10 0.3× 15 0.6× 50 181
Morgan Rouprêt France 8 69 0.8× 26 0.4× 15 0.4× 17 0.5× 14 0.6× 20 141
Holly Ní Raghallaigh United Kingdom 7 78 0.9× 26 0.4× 24 0.6× 8 0.2× 3 0.1× 16 123
Bijun Lian China 6 72 0.8× 25 0.4× 31 0.8× 7 0.2× 11 0.5× 17 103
Benkang Shi China 7 59 0.7× 41 0.6× 34 0.9× 116 3.5× 24 1.0× 12 217
Victor Kucherov United States 6 43 0.5× 206 3.0× 177 4.7× 48 1.5× 25 1.0× 13 340
Marios Marcou Germany 4 20 0.2× 77 1.1× 59 1.6× 9 0.3× 8 0.3× 12 113
Pradeep Bose United Kingdom 5 38 0.4× 36 0.5× 17 0.4× 14 0.4× 3 0.1× 6 111
Jin Ye-ning China 4 41 0.5× 67 1.0× 80 2.1× 16 0.5× 10 0.4× 5 147
Phillip R. Cooper United States 8 110 1.2× 37 0.5× 11 0.3× 5 0.2× 15 0.6× 13 142

Countries citing papers authored by Xiuyi Pan

Since Specialization
Citations

This map shows the geographic impact of Xiuyi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuyi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuyi Pan more than expected).

Fields of papers citing papers by Xiuyi Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuyi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuyi Pan. The network helps show where Xiuyi Pan may publish in the future.

Co-authorship network of co-authors of Xiuyi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuyi Pan. A scholar is included among the top collaborators of Xiuyi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuyi Pan. Xiuyi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pan, Xiuyi, Linmao Zheng, Mengxin Zhang, et al.. (2025). Fumarate activates the IL-6/JAK/STAT3 pathway by inhibiting KDM4C-mediated H3K36me3 demethylation in FH-knockdown renal cancer cells. British Journal of Cancer. 133(11). 1611–1624.
2.
Zhang, Mengxin, Ying Yang, Jue Hu, et al.. (2025). Clinicopathologic and Molecular Study of TFEB-altered Renal Cell Carcinomas. The American Journal of Surgical Pathology. 50(1). 84–102. 1 indexed citations
3.
4.
Yin, Xiaoxue, Xingming Zhang, Jiayu Liang, et al.. (2024). Benign metastasizing fumarate hydratase (FH)-deficient uterine leiomyomas: clinicopathological and molecular study with first documentation of multi-organ metastases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 223–231. 2 indexed citations
5.
Zheng, Linmao, Tao Luo, Mengxin Zhang, et al.. (2024). A primary intracranial neuroepithelial neoplasm with novel TCF3::BEND2 fusion: a case report. Acta Neuropathologica Communications. 12(1). 175–175. 1 indexed citations
6.
Wang, Ruyue, Xiuyi Pan, Zhengzheng Su, et al.. (2023). A novel intronic circular RNA circFGFR1int2 up-regulates FGFR1 by recruiting transcriptional activators P65/FUS and suppressing miR-4687-5p to promote prostate cancer progression. Journal of Translational Medicine. 21(1). 840–840. 4 indexed citations
7.
Zheng, Linmao, Xingming Zhang, Xiuyi Pan, et al.. (2023). AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma. Modern Pathology. 36(11). 100303–100303. 16 indexed citations
8.
9.
10.
Pan, Xiuyi, Xiaoxue Yin, Qianqi Liu, et al.. (2022). The roles of mutated SPINK1 gene in prostate cancer cells. Mutagenesis. 37(5-6). 238–247. 1 indexed citations
11.
Su, Zhengzheng, Mengni Zhang, Han Luo, et al.. (2022). circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression. Cancer Science. 114(4). 1378–1395. 4 indexed citations
12.
Pan, Xiuyi, Mengni Zhang, Jin Yao, et al.. (2019). Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases. Journal of Clinical Pathology. 72(11). 748–754. 21 indexed citations
13.
Nie, Ling, Xiuyi Pan, Mengni Zhang, et al.. (2019). The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center. The Prostate. 79(8). 819–825. 9 indexed citations
14.
Su, Zhengzheng, Mengni Zhang, Miao Xu, et al.. (2018). MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components. The Prostate. 78(5). 343–352. 11 indexed citations
15.
Pan, Xiuyi, Ling Nie, Xiaoxue Yin, et al.. (2017). [Prognostic Significance of ERG Gene Rearrangement and Protein Expression in Prostate Cancer].. PubMed. 48(1). 66–70. 2 indexed citations
16.
Zhang, Xingming, Pengfei Shen, Xiaoxue Yin, et al.. (2016). Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. Scientific Reports. 6(1). 23503–23503. 37 indexed citations
17.
Pan, Xiuyi, Xingming Zhang, Jing Gong, et al.. (2016). The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer. The Prostate. 76(9). 823–833. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahmut Akgül Breakdown of academic impact, for papers by Morgan Rouprêt Breakdown of academic impact, for papers by Holly Ní Raghallaigh Breakdown of academic impact, for papers by Bijun Lian Breakdown of academic impact, for papers by Benkang Shi Breakdown of academic impact, for papers by Victor Kucherov Breakdown of academic impact, for papers by Marios Marcou Breakdown of academic impact, for papers by Pradeep Bose Breakdown of academic impact, for papers by Jin Ye-ning Breakdown of academic impact, for papers by Phillip R. Cooper
Rankless by CCL
2026